title: Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.
authors.forename: Richard A
authors.initials: RA
authors.lastname: Feelders
authors.forename: Christiaan
authors.initials: C
authors.lastname: de Bruin
authors.forename: Alberto M
authors.initials: AM
authors.lastname: Pereira
authors.forename: Johannes A
authors.initials: JA
authors.lastname: Romijn
authors.forename: Romana T
authors.initials: RT
authors.lastname: Netea-Maier
authors.forename: Ad R
authors.initials: AR
authors.lastname: Hermus
authors.forename: Pierre M
authors.initials: PM
authors.lastname: Zelissen
authors.forename: Ramona
authors.initials: R
authors.lastname: van Heerebeek
authors.forename: Frank H
authors.initials: FH
authors.lastname: de Jong
authors.forename: Aart-Jan
authors.initials: AJ
authors.lastname: van der Lely
authors.forename: Wouter W
authors.initials: WW
authors.lastname: de Herder
authors.forename: Leo J
authors.initials: LJ
authors.lastname: Hofland
authors.forename: Steven W
authors.initials: SW
authors.lastname: Lamberts
mesh_terms: D000328:Adult; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000652:urine; D007654:Ketoconazole / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D047748:Pituitary ACTH Hypersecretion / Q000188:drug therapy* / Q000652:urine; D011446:Prospective Studies; D017448:Receptors, Dopamine D2; D017481:Receptors, Somatostatin / Q000037:antagonists & inhibitors; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D018491:Dopamine Agonists; D004873:Ergolines; D017448:Receptors, Dopamine D2; D017481:Receptors, Somatostatin; D013004:Somatostatin; C094573:somatostatin receptor 5; C517782:pasireotide; D000077465:Cabergoline; D007654:Ketoconazole; D006854:Hydrocortisone